However, Igf1, which is downstream of the Cyclin D1 pathway, was upregulated both in tumors and eMCs expressing SS18-SSX1, which might be important for drug resistance in synovial sarcoma treatment [22]. The gene discussed is SSX1; the disease is synovial sarcoma.